Mixed
Gut microbiota composition serves as a predictive biomarker for obesity-related metabolic abnormalities, with specific genera (Bacteroides, Parabacteroides, Blautia, Alistipes, Romboutsia, Roseburia) consistently associated with metabolic health status in obese populations.
Your gut bacteria composition is a strong indicator of your metabolic health risk. If you are obese, specific bacteria levels (like Bacteroides and Roseburia) can predict issues like high blood pressure or lipids. While this paper doesn't prescribe a specific diet, it suggests that interventions targeting these specific microbes (e.g., through prebiotics or probiotics) could help improve metabolic risk. Focus on dietary patterns that support a diverse microbiome, as specific genera are linked to better metabolic outcomes.
six GM markers were shared by obesity patients with various metabolic disorders (Bacteroides, Parabacteroides, Blautia, Alistipes, Romboutsia and Roseburia)... these biomarkers hold the potential to predict obesity-related metabolic abnormalities, and interventions based on these biomarkers might be beneficial to weight loss and metabolic risk improvement.
Why this rating
Large cohort (n=1,914), rigorous statistical methods (Random Forest, PERMANOVA, Spearman correlation), but it is a retrospective observational study, not a randomized controlled trial of an intervention.
Source
Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities
Qiang Zeng et al. · Scientific Reports · 2019
DOI 10.1038/s41598-019-49462-w
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →